Search Within

Karim Wadih Baroudy

Formats
  1. Meeting Abstract (7)
Groups
  1. Bone Marrow Transplant (7)
  2. Center for Hematologic Malignancies (7)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (7)
  4. Department of Medicine (7)
  5. GSK Faculty (7)
  6. Hematologic Malignancies, Division of (7)

More Groups

People
  1. Craig Sauter (7)
  2. Ekaterina Doubrovina (7)
  3. Esperanza Papadopoulos (7)
  4. Richard O'Reilly (7)
  5. Susan Prockop (7)
  6. Stephanie Suser (6)

More People

Years
  1. 2019 (1)
  2. 2018 (1)
  3. 2017 (1)
  4. 2015 (2)
  5. 2014 (2)
Publications
  1. Blood (3)
  2. Biology of Blood and Marrow Transplantation (2)
  3. Cancer Research (1)
  4. Journal of Clinical Oncology (1)
Publishers
  1. American Society of Hematology (3)
  2. Elsevier Inc. (2)
  3. American Association for Cancer Research (1)
  4. American Society of Clinical Oncology (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of donor and 'third party' (Tabelecleucel) EBV-specific T cells for treatment of central nervous system (CNS) EBV-PTLD
    Meeting Abstract

    Prockop, S. E.; Suser, S.; Doubrovina, E. S.; Castro-Malaspina, H.; Papadopoulos, E. B.; Sauter, C. S.; Young, J. W.; Szenes, V.; Slocum, A.; Baroudy, K.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Adoptive therapy with EBV-specific T cells for treatment of CNS EBV post-transplant lymphoproliferative disease arising after hematopoietic stem cell transplant or solid organ transplant
    Meeting Abstract

    Prockop, S.; Suser, S.; Doubrovina, E.; Castro-Malaspina, H. R.; Papadopoulos, E. B.; Sauter, C. S.; Young, J. W.; Szenes, V.; Slocum, A.; Baroudy, K.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Adoptive T-cell therapy with 3rd party CMV-pp65-specific CTLs for CMV viremia and disease arising after allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Rodriguez-Sanchez, I.; Hasan, A. N.; Barker, J.; Castro-Malaspina, H. R.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Kernan, N. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Epstein-Barr virus-specific cytotoxic T lymphocytes for treatment of rituximab-refractory Epstein-Barr virus-associated lymphoproliferative disorder
    Meeting Abstract

    Prockop, S. E.; Doubrovina, E.; Baroudy, K.; Boulad, F.; Khalaf, R.; Papadopoulos, E. B.; Sauter, C.; Szenes, V.; Suser, S.; Wasilewski, G.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Banked EBV-specific T-cells from HLA-partially matched normal donors to induce durable remissions of rituximab refractory EBV(+) B-cell lymphomas post hematopoietic and organ allografts
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Baroudy, K.; Boulad, F.; Khalaf, R.; Papadopoulos, E. B.; Sauter, C. S.; Szenes, V.; Suser, S.; Wasilewski, G.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Third party donor derived CMV specific T vells for the treatment of refractory CMV viremia and disease after hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S. E.; Hasan, A.; Koehne, G.; Doubrovina, E.; Sauter, C. S.; Barker, J. N.; Baroudy, K.; Boulad, F.; Giralt, S.; Khalaf, R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Third party donor derived EBV specific T cells for the treatment of refractory EBV-related post-transplant lymphomas
    Meeting Abstract

    Prockop, S. E.; Doubrovina, E. S.; Barker, J. N.; Baroudy, K.; Boulad, F.; Kernan, N. A.; Khalaf, R.; Kobos, R.; Papadopoulos, E.; Sauter, C.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save